Insulins Roland Halil, BScPharm, ACPR, PharmD

Slides:



Advertisements
Similar presentations
Medications Insulin. Without Insulin With Treatment of Insulin.
Advertisements

In-Patient Management of Hyperglycemia Rey Vivo, MD Assistant Professor of Medicine Texas Tech University Health Sciences Center.
Canadian Diabetes Association Clinical Practice Guidelines Pharmacologic Management of Type 2 Diabetes Chapter 13 William Harper, Maureen Clement, Ronald.
1 INTENSIVE INSULIN THERAPY J. Robin Conway M.D. Diabetes Clinic, Smiths Falls, ON

Chris Harrold SpR Diabetes & Endocrinology.  Diabetes is common  15% of all inpatients  50% of those are on insulin  20% of patients experienced an.
Stepwise approach to inpatient diabetes management Erin Keely.
Diabetes (abridged!). Who needs screening for DM? Age >45 Obese – BMI >25 1 st degree relative with DM Racial groups: –African American –Hispanic American.
1 Successful Transition to Insulin Therapy in T2DM Merri Pendergrass, M.D., Ph.D. Endocrinology, University of Arizona All Faculty, CME Planning Committee.
Insulin Diabetes Outreach (June 2011). 2 Insulin Learning outcomes >Understand the difference between insulin therapy in type 1 diabetes as compared to.
Canadian Diabetes Assocaition Clinical Practice Guidelines Pharmacotherapy in Type 1 Diabetes Chapter 12 Angela McGibbon, Cindy Richardson, Cheri Hernandez,
Ted D. Williams PharmD Candidate OSU College of Pharmacy
Diabetes Mellitus Ibrahim Sales, Pharm.D. Assistant Professor of Clinical Pharmacy King Saud University
Insulin therapy.
DIABETES MELLLITUS Strategies for Achieving Control in an Office Setting.
Kathryn A. Hanavan ANP-BC; BC-ADM Harold Schnitzer Diabetes Health Center September 12,
INSULIN THERAPY IN TYPE 1 DIABETES
Basal and Meal Time Insulin Case Study
OnsetPeakDuration Rapid Acting Lispro (Humalog) min3-5 hours Aspart (Novolog)15-30 min1-3 hours3-5 hours Intermediate Acting NPH1-4 hours5-10.
Inpatient Glycemic Management
Diabetes Update Division of Endocrinology Department of Medicine Wayne State University Medical School Detroit, Michigan Part 3 of 3.
Davida F. Kruger, MSN,APN-BC,BC-ADM Certified Nurse Practitioner Division of Endocrinology, Diabetes, Bone and Mineral Disorders Henry Ford Health System.
Basal Bolus: The Strategy for Managing All Diabetes Fall, 2003 Paul Davidson, MD, FACE Atlanta Diabetes Associates Atlanta, Georgia.
Insulin Glargine (Lantus) Lantus is a long-acting insulin that should be injected below the skin once daily as directed by your doctor. Take Lantus the.
Hypoglycemia & Hyperglycemia Dave Joffe, BSPharm, CDE, FACA Part 2.
Insulins Roland Halil, BScPharm, ACPR, PharmD Clinical Pharmacist, Bruyere Academic Family Health Team Assistant Professor, Dept of Family Medicine, U.
Diabetes Update: Michael Gottschalk, M.D, Ph.D.
ADDITIONAL SLIDES FOR ASSIST WITH COMPREHENSION OF LAB CONTENT-MODULE FIVE-DM DENISE TURNER, MS-N.ED, RN, CCRN.
Insulin initiation in Type 2 Diabetes
What Key Personal Need To Know INSULIN ADMINISTRATION.
Diabetes Mellitus Part 2 Kathy Martin DNP, RN, CNE.
Quality of Life Matters NOT TOO HIGH… NOT TOO LOW… A PLAN FOR OPTIMIZING DIABETES MANAGEMENT IN NURSING HOMES 5. Insulin: Part 1.
Representative insulin regimens for the treatment of diabetes
Medications Used in the Treatment of Diabetes Mellitus
Small concise points on Insulin
Insulins Roland Halil, BScPharm, ACPR, PharmD
Insulin Initiation and Titration
Insulin Type (trade name)
Jill Little Diabetes Specialist Nurse
Inpatient Glycemic Management
Representative insulin regimens for the treatment of diabetes
Monitoring and Management
Pharmacy Protocol for Insulin Dosing in the Hospitalized Patient
Representative insulin regimens for the treatment of diabetes
Dr. Sasan Zaeri (PharmD, PhD) Department of Pharmacology, BPUMS
Recommendation In people with clinical cardiovascular disease in whom glycemic targets are not met, a SGLT2 inhibitor with demonstrated cardiovascular.
Representative insulin regimens for the treatment of diabetes
Representative insulin regimens for the treatment of diabetes
Representative insulin regimens for the treatment of diabetes
First step into insulin therapy
Diabetes Medications in the Top 200
Insulins Roland Halil, BScPharm, ACPR, PharmD
Comparison of Basal insulins, Initiation and titration of Lantus
Karen McAvoy RN, MSN, CDE Joslin Diabetes Center
Innovations in Insulin
Diabetes Jessica Tagerman PharmD
Jill Little Diabetes Specialist Nurse
Injectable Therapies in Diabetes
Insulin Safety know your insulins! There are many! Humalog® Mix25 Humalog® Mix50 Humulin® I Humulin® M3 Humulin® S Humalog® U-100 Humalog® U-200.
T1DM: Insulin Initiation
Diabetes.
Treatment Pathway for Adults with Type 1 Diabetes
Approach to starting and adjusting insulin in type 2 diabetes.
Glycemic Management in Adults with Type 1 Diabetes
Diabetes Source: Medicine Issue Date: 12/2010
INSULINS Dr.R.Sajjad december INSULINS Dr.R.Sajjad december 2018.
Insulin Delivery Systems Atlanta Diabetes Associates
Inpatient Insulin Management on the Wards
Insulin in Type 2 Diabetes
CPPE Optimise: Insulins
Presentation transcript:

Insulins Roland Halil, BScPharm, ACPR, PharmD Clinical Pharmacist, Bruyere Academic Family Health Team Assistant Professor, Dept of Family Medicine, U of Ottawa July 2016

**Animal-source insulin- demand has decreased now that human insulin is available. There are some patients who cannot control their diabetes on human insulin. **Beef insulin also available through Health Canada’s Special Access Programme. Humalog 388 For the treatment of patients with Type 1 diabetes mellitus.   LU Authorization Period: Indefinite. 389 For the treatment of patients with Type 2 diabetes mellitus using insulin in an intensive regimen with 3 or more injections per day or an insulin pump.   LU Authorization Period: Indefinite. 390 For the treatment of patients with Type 2 diabetes mellitus who are either experiencing recurrent hypoglycemia OR are unable to achieve adequate post-prandial glucose control while on a less intensive regimen of regular insulin (1-2 injections per day). NovoRapid Humulin R, NPH vial $15, 3X5 cartridges 32$ Humalog, Novorapid vial 23$, 3X5 cartidges $46 New Drugs/Drug News vol 24 (3): May/June 2006

Insulins Long = Basal Short = Prandial Premixed Which to choose? NPH, (N) Glargine (Lantus) Detemir (Levemir) Short = Prandial Short Regular (R) Toronto Rapid Lispro (Humalog) Aspart (NovoRapid) Glulisine (Apidra) Premixed 30/70 (and 10/90, 20/80, 40/60, 50/50) Humalog Mix-25, NovoMix-30 Which to choose?

Basic Concepts Hyperglycemia = Chronic Hypoglycemia = Acute So, go after Hypo’s first! Fed: 6h/24h = 25% Fasting: 18h/24h = 75% So, go after Fastings first! AM affects PM & HS So, go after AM first! ?Any hypo’s?- fix ‘em! then, FBS AM FBS Noon FBS PM FBS HS 2h PPG AM 2h PPG Noon 2h PPG PM

Humalog Mix-25, NovoMix-30 (Rapid + NPH) Insulins Long – Basal NPH, (N) Glargine (Lantus) Detemir (Levemir) Short – Prandial Short Regular (R) Toronto Rapid Lispro (Humalog) Aspart (NovoRapid) Glulisine (Apidra) Premixed 30/70 (and 10/90, 20/80, 40/60, 50/50) (R + NPH) Humalog Mix-25, NovoMix-30 (Rapid + NPH) Now, which to choose?

Rational Prescribing FOUR steps to Rational Prescribing: Benefit Harm Cost Convenience

Long – Basal Insulins Benefit: NPH = Lantus = Levemir = NPH Equivalent Morbidity benefits, A1c lowering effect Despite the marketing: Kinetics don’t affect overall efficacy: Slowest absorption: Thigh (best for basal insulins) Fastest absorption: Abdomen (best for prandial insulins) Lots of Lantus is injected BID NPH can be used QHS for some

Long – Basal Insulins Harm: All: NPH: Lantus / Levemir: Hypoglycemia Peak effect at ~ 8hrs (4-10hrs) Risk of hypoglycemia (~ 5%? vs “peakless” insulins) Lantus / Levemir: Insulin analogues Increased breast cancer risk? more research needed

Long – Basal Insulins Cost: Convenience: All: covered under ODB N.B. No Rx required for any insulins – all OTC NPH: ~ $40 Lantus: ~ $90 Levemir: ~ $100 Convenience: All sc injections, via penfills All QD – BID

Bottom Line – Basal Insulins All equivalent Choose therapy based on cost (NPH) For the very small proportion suffering from hypoglycemia due to the peak effect of NPH or lamenting BID dosing, consider Lantus or Levemir.

Starting Basal Insulin Fancy Way: calculate unit/kg dose = 0.1 - 0.2u/kg/day sc Risk hypoglycemia on first dose – lose your patient’s buy-in forever. Primary Care Method: Initiate 5u or 10u qhs sc Titrate by 1-2u q3-4d until AM FBS = 4 - 7 mmol/L 10% titrations If dose = 30’s – increase by 3 units If dose = 40’s – increase by 4 units etc. etc.

Rx NPH Needle tips – 28G - 6mm N.B. (Please teach pt pen technique) Sig: 5u qhs sc or ud M: 1 box penfills Repeat x 12 Needle tips – 28G - 6mm Sig: ud M: 1 box r x 12 N.B. (Please teach pt pen technique)

Humalog Mix-25, NovoMix-30 (Rapid + NPH) Insulins Long = Basal NPH, (N) Glargine (Lantus) Detemir (Levemir) Short = Prandial Short Regular (R) Toronto Rapid Lispro (Humalog) Aspart (NovoRapid) Glulisine (Apidra) Premixed 30/70 (and 10/90, 20/80, 40/60, 50/50) (R + NPH) Humalog Mix-25, NovoMix-30 (Rapid + NPH)

Short – Prandial Insulins Efficacy Equivalent reduction in morbidity, HgbA1c

Short – Prandial Insulins Toxicity Hypoglycemia Rapid insulins better reflect physiological effect of pancreatic insulin (vs Regular insulin) More important in CKD (=longer insulin t½ )

Short – Prandial Insulins Cost All covered under ODB Regular (R) / Toronto ~ $40 NovoRapid (aspart) ~ $56 Humalog (lispro) ~ $55 Apidra (glulisine) ~ $48 Convenience All injected with meals Regular insulin injected 30-45 min before meal Rapid insulin can be taken with meal Reduced risk of hypo if pt injects, then forgets to eat

Bottom Line – Prandial Insulins All equivalent Choose therapy based on cost / familiarity Rapid insulins reflect pancreatic insulin release better than [R]/Toronto. The worse the CrCL, the more important this fact becomes.

Starting Prandial Insulin Fancy Way: Total dose: 0.5u/kg 40% of total dose - basal insulin qHS 20% of total dose TID with meals (60%) – prandial insulin 15-30 min before meals Eg. 80kg pt – 0.5u/kg = 16u basal (40%); 8u TID (20% x 3 = 60%) Primary Care Method: Start 5u sc with meals Titrate AM to HS to target Monitor 2h PPG Start injection TID or only single meal as required If poor control: inj TID sc; If mediocre control: inj qAM sc Still aim for ~ 2/3rds split (40% basal / 60% prandial)

Humalog Mix-25, NovoMix-30 (Rapid + NPH) Insulins Long = Basal NPH, (N) Glargine (Lantus) Detemir (Levemir) Short = Prandial Short Regular (R) Toronto Rapid Lispro (Humalog) Aspart (NovoRapid) Glulisine (Apidra) Premixed 30/70 (and 10/90, 20/80, 40/60, 50/50) (Reg + NPH) Humalog Mix-25, NovoMix-30 (Rapid + NPH)

Pre-mixed Insulins NovoMix-30 = Humalog Mix25 (equivalent) Efficacy All ~ 30% short / 70% long Toxicity Hypoglycemia (less with Rapid vs Regular insulin) Cost: ~$53 (Rapids) ~$40 (Regular 30/70) Convenience ~ Rapids can be injected with meal

Starting Pre-mixed Insulins Fancy Way: Estimate total starting daily dose (0.3-0.6 units/kg) Divide daily dose: 2/3 before breakfast; 1/3 before supper Primary Care Method: From scratch: Start 5-10u QD-BID and titrate From other insulins: Calculate approximate amount of basal and prandial units and divide 2/3rd - 1/3rd AM and PM

Pearls Insulin is 2nd line after metformin No need to save it for last! Better than adding a 3rd PO drug Better efficacy, lower toxicity, better studied Improve buy-in from patient: “Natural” supplement Only BID glucochecking at alternating times required: Pre-Breakfast + Post-Breakfast, then Pre-Breakfast + Pre-Lunch, then Pre-Breakfast + Post-Lunch, then Pre-Breakfast + Pre-Supper, then Pre-Breakfast + Post-Supper, then Pre-Breakfast + Pre-Bedtime Repeat

Pearls (cont’d) D/C secretagogues after starting insulin to reduce risk of hypo’s. Eg. Sulfonylureas, meglitinides Black box warning against combo with glitizones! (Actos, Avandia)